U.S. Dept of Health gives immunity to Ebola Vaccine manufacturers

(Reuters) – The U.S. Department of Health and Human Services on Tuesday offered liability protections to drugmakers rushing to develop Ebola vaccines and urged other countries to follow suit. Health and Human Services (HHS) Secretary Sylvia Burwell made the announcement as part of the Public Readiness and Emergency Preparedness (PREP) Act in a move aimed at encouraging the development and availability of experimental Ebola vaccines. The...

Continue reading

The First Attempt to Digitize Ebola Health Records

Ebola treatment in West Africa is going digital. Keeping detailed patient records during the Ebola outbreak can be a nightmare. Currently, health care workers use very basic methods, ranging from scanning files to writing on white boards to calling results across rooms to simple memorization. But the International Rescue Committee (IRC), a crisis organization, is about to change that by bringing in electronic health records to its new Ebola treatment...

Continue reading

No serious side effects in Ebola vaccine test

(Reuters) – The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday. The shot, one of several being fast-tracked through clinical trials in the hope they can be approved for use in the Ebola epidemic raging in West Africa, is undergoing initial human safety tests at the University Hospitals...

Continue reading

Strategies for Fighting Ebola

Where do we stand in the fight against Ebola — and what should be done now? Columbia is convening leading experts — from the University and other institutions – to recommend and discuss specific strategies to: Arrest the transmission of the virus and accelerate the delivery of needed care. Marshal the financial resources – and the health care personnel – required to address the crisis. Mobilize and coordinate international, national,...

Continue reading

Sifting Through Genes in Search of Answers on Ebola

CAMBRIDGE, Mass. — An old two-story brick building in a shabby part of town, formerly a distribution center for Budweiser beer, is now the world’s most powerful factory for analyzing genes from people and viruses. And it is a factory. At any given time, 10,000 tiny test tubes each holding a few drops of gene-containing fluid are being processed by six technicians, working 24 hours a day, 365 days a year — two on the night shift — using 50 dishwasher-sized...

Continue reading

4 Things Working With HIV Can Teach Us About Fighting Ebola

(RNS) Every year on Dec. 1, World AIDS Day focuses attention on the disease that last year infected another 2.1 million people and took more than 1.5 million lives, according to UNAIDS. After 26 years of World AIDS Days, the death toll stands at a staggering 39 million. And yet, within the HIV/AIDS community there is optimism. Many believe new infections can be stopped completely, and the annual death toll has been cut in half… (read mo...

Continue reading

Is the Blood of Ebola Survivors an Effective Treatment?

When the World Health Organization recently named blood transfusions from Ebola survivors as its priority experimental therapy for the disease ravaging west Africa there was only one major problem: no data indicating that such transfusions work. Blood plasma from survivors contains antibodies that could potentially trigger an immune system response in patients, which would bolster their ability to fight the virus, but clinical data suggesting...

Continue reading

Ebola vaccine from Glaxo passes early safety test

(Reuters) – An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks, is primarily aimed at assessing how safe the vaccine is. But the immune response...

Continue reading

Trial Of 15-Minute Ebola Test To Start in Guinea

A portable test that can detect the Ebola virus in blood and saliva samples within 15 minutes will go through a trial run in coming weeks in Guinea, one of the three countries affected by the Ebola virus outbreak in West Africa, researchers announced Friday. The 15-minute test is roughly six times faster than currently available technologies. The trial will help researchers establish if the test can be scaled up and used more widely… (read...

Continue reading

The Race for an Ebola Vaccine

Over the summer, as it became clear that the Ebola outbreak in West Africa was one of the worst public-health emergencies in recent memory, executives at Merck met at the company’s New Jersey headquarters to figure out how to respond. Public-health organizations were also getting in touch with people at Merck, asking for help. At several meetings, the executives cycled through the possibilities: Should they donate medicines? Financially support...

Continue reading